Royalty Pharma plc Class A Ordinary Shares vs Direxion Daily Semiconductor Bear 3X Shares — how do they compare? Royalty Pharma plc Class A Ordinary Shares trades at $56.2 (market cap $25.27B), while Direxion Daily Semiconductor Bear 3X Shares trades at $32.09 (market cap $1.96B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 12.9× Direxion Daily Semiconductor Bear 3X Shares's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while Direxion Daily Semiconductor Bear 3X Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Royalty Pharma plc Class A Ordinary Shares for 0 Days and Direxion Daily Semiconductor Bear 3X Shares for 11 Days on average.
| RPRX | SOXS | |
|---|---|---|
Market Cap | $25.27B | $1.96B |
Volume | 3,671,183 | 113,512,541 |
Sector | Health | Leveraged / Inverse |
52-Week High | $63.96 | $988.00 |
52-Week Low | $35.44 | $29.62 |
Typical Hold Time | 0 Days | 11 Days |
Enterprise Value | $32.50B | — |
Dividend Yield | 1.66% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SOXS, the Direxion Daily Semiconductor Bear 3X ETF, trades at $30.645, up 3.43% today amid bearish technical signals. The ETF shows strong bearish momentum with moving averages indicating sell pressure, though oscillators are neutral. Recent news highlights SOXS as a tactical instrument for semiconductor sector declines, benefiting from AI stock volatility and chip sector weakness.
Outlook remains highly speculative given SOXS's inverse 3x leverage structure. Investment opportunity exists for short-term bearish semiconductor bets, but risks include extreme volatility, decay from daily reset, and persistent AI demand supporting chip stocks. This ETF is unsuitable for long-term holdings.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →SOXS is a leveraged ETF that seeks daily investment results corresponding to 300% of the inverse (opposite) of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bearish (short) position on the semiconductor sector. Due to the effects of compounding and leverage, SOXS is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXS →